88Q.F

4basebio PLC
FrankfurtEUREQUITY DELAYED
Last price
3.74
■ 0.00 (0.00%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
Prev close
3.74
Day high
3.74
Day low
3.74
Volume
13
Market cap
P/E (TTM)
52W range
3.74 – 10.20

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-33.21% -32.1%
1M
-32.61% -36.0%
3M
-32.00% -34.5%
6M
-41.56% -53.5%
YTD
-41.10% -53.2%
1Y
-62.03% -82.3%
3Y
-45.00% -120.1%
5Y
-53.54%

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on 88Q.F open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.69M$933.00K$506.00K$268.00K +81.5%
Operating revenue $1.69M$933.00K$506.00K$268.00K +81.5%
Cost of revenue $719.00K$303.00K$166.00K$29.00K +137.3%
Gross profit $974.00K$630.00K$340.00K$239.00K +54.6%
Research & development $5.12M$4.68M$2.22M$2.08M +9.4%
Selling, general & admin $2.25M$1.76M$1.09M$1.43M +27.6%
Total operating expense $17.64M$13.42M$8.51M$5.91M +31.4%
Operating income -$16.66M-$12.79M-$8.17M-$5.67M -30.3%
Net interest income -$3.00K-$612.00K-$302.00K-$89.00K +99.5%
Pre-tax income -$17.60M-$12.65M-$8.35M-$5.93M -39.1%
Tax provision -$698.00K-$321.00K-$689.00K-$779.00K -117.4%
Net income -$16.91M-$12.33M-$7.67M-$5.15M -37.1%
Net income to common -$16.91M-$12.33M-$7.67M-$5.15M -37.1%
Basic EPS -1.09-0.94-0.62-0.42 -16.0%
Diluted EPS -1.09-0.94-0.62-0.42 -16.0%
EBIT -$16.72M-$11.90M-$8.05M-$5.84M -40.4%
EBITDA -$15.57M-$10.97M-$7.34M-$5.41M -42.0%
Basic shares 15.51M13.12M12.32M12.32M +18.3%
Diluted shares 15.51M13.12M12.32M12.32M +18.3%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
5.04
-25.82% from price
SMA 20
5.26
-28.84% from price
SMA 50
5.57
-32.91% from price
SMA 100
5.58
-33.02% from price
SMA 200
6.22
-39.84% from price
EMA 12
4.85
-22.85% from price
EMA 26
5.20
-28.14% from price
EMA 50
5.42
-31.06% from price
RSI (14)
13.6
Oversold
MACD (12,26,9)
-0.36
Hist -0.20
ATR (14)
0.33
8.77% of price
Realised vol 30D
117.9%
Annualised
Bollinger upper
6.54
20, 2σ
Bollinger lower
3.97
20, 2σ
50 / 200 cross
Death
5.57 vs 6.22
Trend bias
Below 200
-39.84%

Options chain

Account required
ExpirySpot 3.74
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.04
Less volatile than market
Correlation to SPY
-0.01
Largely independent
Realised vol 30D
117.9%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-63.3%
Peak to trough
Max drawdown 5Y
-81.8%
Peak to trough
ATR 14
0.33
8.77% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.